Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Rovira

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
Nature Reviews. Neurology|May 19, 2026
Rethinking prognosis in multiple sclerosis: a multiaxial perspectiveLuca Prosperini, Carla Tortorella, Frederik Barkhof, et al.
Neurology|August 14, 2016
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Carmen Espejo, Herena Eixarch, et al.
Neurology|October 30, 2021
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS StudyMassimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Journal of Neurology|July 5, 2020
Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohortAlexandra de Sitter, Tom Verhoeven, Jessica Burggraaff, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2023
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS StudySerena Ruggieri, Luca Prosperini, Sarmad Al-Araji, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2024
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTsAgustin Pappolla, Cristina Auger, Augusto Sao-Aviles, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Nature Reviews. Neurology|May 19, 2026
Rethinking prognosis in multiple sclerosis: a multiaxial perspectiveLuca Prosperini, Carla Tortorella, Frederik Barkhof, et al.
Neurology|August 14, 2016
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Carmen Espejo, Herena Eixarch, et al.
Neurology|October 30, 2021
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS StudyMassimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Journal of Neurology|July 5, 2020
Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohortAlexandra de Sitter, Tom Verhoeven, Jessica Burggraaff, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2023
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS StudySerena Ruggieri, Luca Prosperini, Sarmad Al-Araji, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2024
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTsAgustin Pappolla, Cristina Auger, Augusto Sao-Aviles, et al.
Pageof 20